Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
and JavaScript.
Engineering and manipulating phase-separated liquid organelles is the latest frontier in the quest to mimic and interrogate living systems at the molecular level.
Low levels of uric acid and tyrosine in sweat are detected in patients with gout and healthy individuals with an entirely laser-engraved wearable sensor.
A type I CRISPR–Cas system, rather than the conventional type II CRISPR systems, is adapted for gene editing by fusing Cascade to the FokI nuclease domain.
Artificial intelligence-powered drug discovery is capturing breathless headlines, drug company deals, and investor capital, but the acceleration it promises will not happen overnight.